News/ News/ Oncology Clovis signs radiopharmaceuticals R&D deal with German biotech 3B Richard Staines cancer, Clovis, R&D, radiopharmaceuticals 0 Comment Clovis Oncology has become the latest pharma to invest in radiopharmaceuticals, signing a licensing and collaboration deal with Share X Clovis signs radiopharmaceuticals R&D deal with German biotech 3B https://pharmaphorum.com/news/clovis-signs-radiopharmaceuticals-rd-deal-with-german-biotech-3b/
Oncology/ Views & Analysis/ Views and analysis Janssen CAR-T is Priority Medicine in EU, and more Richard Staines BMS-Celegene merger, CAR T, Clovis Oncology, Janssen, radiopharmaceuticals, Rubraca 0 Comment European regulators are to hasten development of Janssen’s CAR-T therapy for patients with multiple myeloma, after promising early-stage Share X Janssen CAR-T is Priority Medicine in EU, and more https://pharmaphorum.com/views-analysis-oncology/janssen-car-t-is-priority-medicine-in-eu-and-more/
News/ News/ Oncology/ Top stories Fusion raises $105m for radiopharmaceutical trials Richard Staines Bayer, cancer, Fusion Pharmaceuticals, Novartis, radiopharmaceuticals 0 Comment Radiopharmaceuticals are already well established in imaging technology for a range of diseases – but their use to Share X Fusion raises $105m for radiopharmaceutical trials https://pharmaphorum.com/news/fusion-raises-105m-towards-radiopharmaceutical-trials/
BMS-Celegene merger, CAR T, Clovis Oncology, Janssen, radiopharmaceuticals, Rubraca
0 Comment
